Medicare Enrolled
Jessica Hellyer
Internal Medicine · Philadelphia, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Hellyer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Hellyer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Hellyer
Jessica Hellyer is an internal medicine specialist in Philadelphia, PA, with 12 years of NPI registration. Based on federal Medicare data, Hellyer performed 48,329 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Hellyer received a total of $12,676 from 22 pharmaceutical and/or device companies across 59 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Hellyer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 0% volume in PA
$12,676 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗48,329
Medicare services
Top 0% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 13,600 | $43 | $132 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
9,460 | $0 | $3 |
| Anti-nausea injection (aprepitant) | 9,360 | $1 | $8 |
| Paclitaxel chemotherapy injection | 3,805 | $0 | $8 |
| Lanreotide injection, 1 mg A 1 mg injection of lanreotide medication administered into the body. |
3,240 | $44 | $201 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,268 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 911 | $0 | $11 |
| Anti-nausea injection (Aloxi/palonosetron) | 890 | $1 | $114 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
519 | $8 | $40 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
485 | $12 | $74 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
406 | $8 | $12 |
| Injection, potassium chloride, per 2 meq | 385 | $0 | $1 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
360 | $94 | $1,348 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
307 | $69 | $177 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
294 | $2 | $345 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
289 | $106 | $472 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
251 | $1 | $94 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $99 | $266 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
136 | $11 | $71 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
94 | $10 | $53 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
89 | $53 | $232 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
84 | $0 | $1 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
75 | $2 | $34 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $10 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
59 | $53 | $803 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
59 | $187 | $900 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
57 | $23 | $105 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
54 | $93 | $269 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
53 | $24 | $111 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
52 | $6 | $135 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
47 | $26 | $176 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $44 | $110 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
39 | $1 | $23 |
| New patient office visit, complex (60-74 min) | 37 | $164 | $513 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
34 | $18 | $88 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
29 | $45 | $199 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $138 | $359 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
26 | $1 | $18 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
24 | $17 | $69 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
23 | $60 | $250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
22 | $50 | $225 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
21 | $15 | $71 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
18 | $28 | $120 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $53 | $265 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
14 | $30 | $169 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $133 | $409 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
11 | $27 | $159 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
94.9% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,676
Total received (2019-2024)
Avg $2,535/year across 5 years
Top 6% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
59
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,516
2023
$65
2022
$95
2021
$500
2019
$500
Payments by company (2024)
Tempus AI, Inc
$10,532
AstraZeneca Pharmaceuticals LP
$295
Novartis Pharmaceuticals Corporation
$135
E.R. Squibb & Sons, L.L.C.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$69
Incyte Corporation
$66
Janssen Biotech, Inc.
$63
Mirati Therapeutics, Inc.
$53
Merck Sharp & Dohme LLC
$46
Aveo Pharmaceuticals, Inc.
$29
Blueprint Medicines Corporation
$24
ARRAY BIOPHARMA INC
$21
Fennec Pharmaceuticals, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Genentech USA, Inc.
$19
Regeneron Healthcare Solutions, Inc.
$16
Gilead Sciences, Inc.
$13
Top 3 companies account for 95.2% of 2024 payments
All-time payments by company (2019-2024) ›
Tempus AI, Inc
$10,532
E.R. Squibb & Sons, L.L.C.
$610
PFIZER INC.
$500
AstraZeneca Pharmaceuticals LP
$295
Novartis Pharmaceuticals Corporation
$135
AVEO Pharmaceuticals, Inc.
$81
Janssen Biotech, Inc.
$76
Takeda Pharmaceuticals U.S.A., Inc.
$69
Incyte Corporation
$66
Mirati Therapeutics, Inc.
$53
Merck Sharp & Dohme LLC
$46
Aveo Pharmaceuticals, Inc.
$29
Blueprint Medicines Corporation
$24
ARRAY BIOPHARMA INC
$21
Fennec Pharmaceuticals, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Genentech USA, Inc.
$19
Dendreon Pharmaceuticals LLC
$19
Telix Pharmaceuticals
$16
Regeneron Healthcare Solutions, Inc.
$16
Celgene Corporation
$14
Gilead Sciences, Inc.
$13
Top 3 companies account for 91.8% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · Alecensa · CALQUENCE · DARZALEX · ENHERTU · ERLEADA · FOTIVDA · Fabhalta · ICLUSIG · ILLUCCIX · IMFINZI · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUTATHERA · OPDIVO · OPDUALAG · PEMAZYRE · PROVENGE · Pedmark · REBLOZYL · SCEMBLIX · TECVAYLI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
4,328
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
PHILADELPHIA VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Hellyer is a mixed practice specialist, with above-average Medicare volume (top 0% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Hellyer experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Hellyer performed 13,600 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Hellyer receive payments from pharmaceutical companies?
Yes. Hellyer received a total of $12,676 from 22 companies across 59 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Hellyer's costs compare to other internal medicine physicians in Philadelphia?
Hellyer's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Hellyer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Philadelphia
Browse internal medicine physicians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Tempus AI, Inc Payments to Doctors
See all physicians who received payments from Tempus AI, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology